These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11298918)

  • 1. Synthesis and characterization of the colistin peptide polymyxin E1 and related antimicrobial peptides.
    Kline T; Holub D; Therrien J; Leung T; Ryckman D
    J Pept Res; 2001 Mar; 57(3):175-87. PubMed ID: 11298918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the Trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues.
    Okimura K; Ohki K; Sato Y; Ohnishi K; Sakura N
    Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1724-30. PubMed ID: 18057747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin B: similarities to and differences from colistin (polymyxin E).
    Kwa A; Kasiakou SK; Tam VH; Falagas ME
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the colistin (polymyxin E1 and E2) biosynthetic gene cluster.
    Tambadou F; Caradec T; Gagez AL; Bonnet A; Sopéna V; Bridiau N; Thiéry V; Didelot S; Barthélémy C; Chevrot R
    Arch Microbiol; 2015 May; 197(4):521-32. PubMed ID: 25609230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
    Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of polymyxin resistance and detection of mcr genes.
    Mlynarcik P; Kolar M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on antibacterial peptide. XVII. Synthesis and antibacterial activity of cyclic alpha-acylpentapeptides related to colistin. VI].
    Kurihara T; Ito H; Tsutida Y
    Yakugaku Zasshi; 1983 Jan; 103(1):80-4. PubMed ID: 6864452
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria.
    Becker B; Butler MS; Hansford KA; Gallardo-Godoy A; Elliott AG; Huang JX; Edwards DJ; Blaskovich MAT; Cooper MA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2407-2409. PubMed ID: 28454673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of susceptibility testing methods for polymyxin.
    Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC
    Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.
    Nation RL; Li J; Cars O; Couet W; Dudley MN; Kaye KS; Mouton JW; Paterson DL; Tam VH; Theuretzbacher U; Tsuji BT; Turnidge JD
    Lancet Infect Dis; 2015 Feb; 15(2):225-34. PubMed ID: 25459221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering polymyxin B minimum inhibitory concentration from colistin minimum inhibitory concentration and vice versa: An analysis on 156 carbapenem-resistant
    Behera B; Jena J; Kar P; Mohanty S; Mahapatra A
    Indian J Med Microbiol; 2018; 36(4):587-589. PubMed ID: 30880712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and antimicrobial activities of ogipeptin derivatives.
    Takiguchi S; Homma H; Fujisawa T; Hirota-Takahata Y; Ono Y; Kizuka M; Ishii Y; Yoshimura S; Nishi T
    Bioorg Med Chem Lett; 2021 Jun; 42():128093. PubMed ID: 33964447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of the polymyxins: where are we now?
    Humphries RM
    Pharmacotherapy; 2015 Jan; 35(1):22-7. PubMed ID: 25329490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
    Zavascki AP
    Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.